-
 WellStar International, Inc. - WLSI
Wellstar/TMI Announces Estimated Three-Year Revenue Projections
Wednesday, January 07, 2009 16:22ET
HOLLAND, OH -- (Marketwire) -- 01/07/09 -- Wellstar International, Inc. (OTCBB: WLSI), a provider of specialized diagnostic software and equipment, announced today its updated revenue projection guidance for fiscal years 2009 through 2011, based on the leasing of its thermal imaging system to long-term care ("LTC") facilities. Wellstar International announced two days ago that the revolutionary imaging system developed by the Company's TMI subsidiary, which can be used for the early detection of pressure ulcers, is now being marketed to the vast LTC market in the U.S. via a special leasing program. This lease program makes these systems now more affordable and essentially a "must-have" for long-term care facilities seeking to curtail potential liabilities and receive a higher rating from CMS under the agency's "pay for performance" standards.
Wellstar/TMI estimates revenues for its fiscal year 2009 will be in excess of $16 million, for 2010, they should be in excess of $69 million, and revenues are projected to be $133 million in 2011. The Company also anticipates that it will be cash flow positive in fiscal year 2009.
The Company's wholly-owned subsidiary, Trillennium Medical Imaging ("TMI"), has begun marketing its thermal imaging system to the approximately 16,000 LTC facilities throughout the United States, and it anticipates installing devices as early as April-2009. The Company has initiated a marketing plan that calls for the installation of 300 FDA approved thermal imaging systems per month through 2010, increasing that number to 400 per month by 2011.
Wellstar/TMI CEO, John Antonio, commented, "We believe that the Company is in a strong position to capitalize on this technology via the leasing program we have implemented. These revenues projected are based on only one intended application of this revolutionary thermal imaging system. We fully expect to market our systems for other applications in the near future. I hope that these revenue projections will now give investors a much clearer picture of our emerging business."
ABOUT WELLSTAR INTERNATIONAL, INC.:
Wellstar International, Inc., through its wholly owned operating subsidiary Trillennium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website, by visiting: Untitled Document.
-
Re: WellStar International, Inc. - WLSI
Wellstar/TMI Joins Fight Against Bedsores Epidemic
HOLLAND, OH--(MARKET WIRE)--Jan 12, 2009 -- Wellstar International, Inc. (OTC BB:WLSI.OB - News ), a provider of specialized diagnostic software and equipment, announced today that its wholly owned subsidiary, Trillennium Medical Imaging ("TMI"), has now joined the fight to quell a growing epidemic among patients in the U.S. that are bed-ridden. Pressure ulcers or decubitus ulcers, commonly known as bedsores, affect hundreds of thousands of patients admitted to healthcare facilities and/or long-term care facilities in the U.S. every year.
The Company's revolutionary thermal imaging system allows nursing staff to objectively identify patterns of injury associated with the development of pressure ulcers, which can lead to an intervention and even prevention of bedsores. According to a recent government report, the number of hospital patients with bedsores has risen dramatically over a 14-year period, leading to longer, more expensive hospital stays. By identifying the tissue changes associated with the development of these wounds prior to skin breakdown, the patient can avoid bedsore occurrences altogether, therefore receiving better care from the nursing staff at these facilities.
Wellstar/TMI CEO John Antonio stated, "We are ready to take this serious epidemic head on. Our team has been aggressively reaching out to educate the caregivers at these facilities regarding our thermal imaging system technology. This is a problem that can be eventually eliminated."
For more information on pressure ulcers, please visit: National Pressure Ulcer Advisory Panel (NPUAP) and Bed Sores - Information and Resources
Based on the existing market for TMI's diagnostic system, Wellstar is anticipating revenues in the current year to exceed $16 million.
ABOUT WELLSTAR INTERNATIONAL, INC.
Wellstar International, Inc., through its wholly owned operating subsidiary Trillennium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website by visiting: Untitled Document
FORWARD-LOOKING STATEMENTS
This press release contains statements, which may constitute 'forward-looking statements' within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. Specific forward-looking statements contained in this press release include, but are not limited to, the Company's assertion that "based on the existing market for TMI's diagnostic system, Wellstar is anticipating revenues in the current year to exceed $16 million." The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contact:
Contact:
Equiti-trend Advisors LLC
(800) 953-3350 Toll-Free, U.S. & Canada
(858) 436-3350 Local or International
-
Re: WellStar International, Inc. - WLSI
Wellstar/TMI Announces Pending Pressure Ulcer Study on Leg and Foot Ulcers
HOLLAND, OH--(MARKET WIRE)--Jan 14, 2009 -- Wellstar International, Inc. (OTC BB:WLSI.OB - News ), a provider of specialized diagnostic software and equipment, announced today that its wholly owned subsidiary, Trillennium Medical Imaging ("TMI"), has begun negotiations for a pressure ulcer study focused on ulcers caused by diabetic foot and venous legs. The Company is currently in talks with several major teaching and research universities, the goal of which is to secure a clinical partner for this study. Wellstar anticipates that the study could start as early as March 2009.
In the U.S. alone, approximately 1.5 million adults are treated each year for pressure ulcers (bedsores) with associated health care costs of over $5 billion. Regrettably, more than 65,000 patients die each year from complications related to these ulcers. Pressure ulcers represent one of four of the most common and costly deficiencies found in long-term care facilities.
A diabetic foot ulcer is a sore or wound that often occurs in people with diabetes; these ulcers may be difficult to heal, susceptible to infection and may lead to amputation of the affected toe, foot or leg if not treated. Over 850,000 chronic diabetic ulcers are diagnosed in the U.S. each year. Approximately 3 million diabetic patients will develop an ulcer and 25% of these patients will have a foot amputated.
Venous leg ulcer is a sore or wound that is caused by poor circulation of blood in the veins of the legs usually caused by faulty valves allowing pressure to build up in the veins. This pressure causes damage to the tiny blood vessels in the skin, making the skin become thin and inflamed, and causing the death of tissue cells leading to the ulcer.
The Company's infrared imaging system involves the detection and recording of skin temperature and injury patterns, providing visual and quantitative documentation to accurately capture body temperature data. The Company's system map changes in skin blood flow by translating temperature data into pictures. The interpretation of these temperatures and thermal patterns can play an important role in detecting these sores at an early stage.
Wellstar/TMI CEO John Antonio stated, "We are looking forward to working with one of the clinical partners that we are currently communicating with about this planned study. Early detection of pressure ulcers is critical and can actually help prevent ulcer outbreaks among patients. The TMI infrared imaging system is a viable tool, and should soon prove to be the medical standard for predicting and preventing pressure ulcers in the medical community. "
ABOUT WELLSTAR INTERNATIONAL, INC.
Wellstar International, Inc., through its wholly owned operating subsidiary Trillennium Medical Imaging, Inc. (TMI), is poised to become a leading diagnostic company in the health care industry. TMI has developed and is marketing fully calibrated and functional, thermal imaging systems that utilize state-of-the-art infrared technologies and proprietary software to accurately and cost-effectively measure physiological changes in the human body. More information on the Company and its unique diagnostic software and product line is available on Wellstar's corporate Website by visiting: Untitled Document
-
Re: WellStar International, Inc. - WLSI
Wow, i like your pick here on WLSI.
The stock has based and looks to be under accumulation before another run. The company should have some solid news on the medical studies coming out soon as well as updates on sales or revenues of their thermal imaging devices.
I would say this is a great time to accumulate before this takes off to much higher levels. Currently sitting at .002, with little downside and very bullsih upside potential in my opinion.
-
Re: WellStar International, Inc. - WLSI
Tested its base at .0015 and lifted off of this.
Decent day today to signal bullish indicators.
Closed at .0017 - Very decent entry and risk/reward right now for this one.
-
Re: WellStar International, Inc. - WLSI
Nice, this one tested its downside support, held and now is heading up, one to keep an eye on for sure.
.0017 x .0018 now.
Last edited by nitrostockz; 03-12-2009 at 02:12 AM.
-
Re: WellStar International, Inc. - WLSI
Closed at .0019 x .002 on 8.8 million in volume, looks like this is heating up, still very good entry prices here.
WLSI maintained its support in the .0015 range and is starting to move off this in a bullish pattern. It seems to move quite easily and is really worth a look at these prices in my opinion.
Keep it on your RADAR list, it should test the .003 resistance first, if it breaks that .0035 and then .0042, at current prices very conservatively it seems to merrit a serious look if nothing else.
-
Re: WellStar International, Inc. - WLSI
Showing decent signs of a breakout point here. One to watch for this week.
-
Re: WellStar International, Inc. - WLSI
News Out:
Wellstar/TMI to Utilize Medical Advisory Board Members in the Marketing of Imaging Systems
Wellstar International, Inc. (OTCBB: WLSI), a provider of specialized diagnostic software and equipment, announced today that its wholly owned subsidiary, Trillenium Medical Imaging (TMI), will utilize Wellstar Medical Advisory Board Members Dr. Courtney Lyder and Edna Atwater to assist with the roll-out of its thermal imaging systems to long-term care (LTC) facilities nationwide.
Dr. Courtney Lyder's background in wound care, hospital operations and nurse care management will play a major role in expanding the Company's client base among the LTC facilities. Lyder's key interest involves identifying early indicators of tissue damage that could help identify pressure ulcers, more commonly known as bedsores, before they become a serious problem. As a result of Lyder's expertise, he was elected to chair a federal advisory panel that revised the nursing home industry's standards of care and strengthened penalties for violating them. He is in great demand as a consultant, both within the nursing home industry and in training state regulators charged with enforcing the regulations.
As an international expert on wound care, Dr. Lyder has delivered more than 500 lectures on this discipline in the United States and internationally. He serves on seven journal editorial boards and reviews manuscripts for 15 medical and nursing journals and has published more than 165 books, book chapters, articles and abstracts. In the past 17 years, Lyder has received as a principal investigator or co-investigator nearly $12 million in research and training grants related to the healthcare needs of older adults.
Dr. Lyder is a senior consultant to the U.S. Department of Health and Human Services where he has influenced development of regulations and policies related to care of elders. In 2007, he was awarded the Thomas Stewart Founder's Award by the National Pressure Ulcer Advisory Panel. This award was created to honor an individual who has made significant contributions in the area of pressure ulcer prevention and treatment, especially in the areas of public policy. Dr. Lyder is also professor and dean of the UCLA School of Nursing.
Between 1994 and 2003, Lyder served on the faculty at Yale University in the School of Nursing, where he directed a number of programs specializing in adult, family, women's and elder care. In 2003, he joined the University of Virginia as an endowed professor of nursing and a professor of internal medicine and geriatrics. He led the University of Virginia's School of Nursing's acute and specialty care department, where he oversaw curriculum for 25 full-time and 22 part-time faculty members. He also designed and directed the school's geriatric nurse practitioner program. In 2006, Lyder was appointed director for diversity initiatives for University of Virginia's School of Nursing and medical center.
Edna Edwards Atwater has been a registered nurse in the state of North Carolina since 1975. Since 1998, Atwater has held several key positions at Duke University Medical Center, including administrator and Director for the Wound Management Institute. She has also served as President of the Dermatology Nurses' Association, Chairperson of the Surgical Core Curriculum, Dermatology Nurses' Association, on the Health Policy Committee, National Federation of Specialty Nursing Organization, and Dermatology Nurses' Association Representative to the National Pressure Ulcer Advisory Panel.
Wellstar's CEO, John Antonio, stated, "I look forward to working with Courtney and Edna in the coming months. Their leadership and experience will certainly provide the Company with an advantage as we start the roll-out of our thermal imaging systems to the LTC facilities. Our country has over 16,000 LTC facilities that are in need to prevent liabilities that are due to the staff's inability to detect pressure ulcers early; our imaging system will play a critical role in minimizing these liabilities."
-
Re: WellStar International, Inc. - WLSI
WLSI now .0029 x .003 hit a high of .0032 so far today, looking good.
|
Checking For Related Data... |
View Profile
View Forum Posts
Private Message
Reply With Quote
Posting Permissions
Bookmarks